OQS
BIOA

Occudo Quantitative Strategies’s BioAge Labs BIOA Stock Holding History

Occudo Quantitative Strategies’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,735
Closed -$235K – 962
2025
Q4 		$235K Sell
17,735
-1,560
-8% -$13.8K 0.02% 556
2025
Q3 		$113K Buy
+19,295
New +$90.4K 0.01% 616

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Occudo Quantitative Strategies's BIOA Position: Q1 2026 in Review

Occudo Quantitative Strategies sold out of BioAge Labs (BIOA) in Q1 2026, closing a stake of 17,735 shares — an estimated $235K sold.

Occudo Quantitative Strategies first reported a position in BIOA in Q3 2025 and held it in 2 quarters. The position peaked at $235K in Q4 2025. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Occudo Quantitative Strategies reported no remaining BioAge Labs position as of Q1 2026 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 17,735 BioAge Labs shares in Q1 2026, an estimated $235K.
  • Occudo Quantitative Strategies first reported a position in BioAge Labs in Q3 2025 and held it in 2 quarters.
  • Occudo Quantitative Strategies's BioAge Labs position peaked at $235K in Q4 2025.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2026, filed 15 May 2026.